Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration

Table 1 Characteristics of patients who underwent proteomic testing

Characteristics	Number	Percent
Age, Mean (SD)	69.2 (8.5)
Age group
50–59	7	10
60–69	31	44
70–79	24	34
≥ 80	7	10
Race/ethnicity
Black or African American	12	19
White	48	76
Other	9	13
Vital status
Alive	59	86
Deceased	10	14
Period of services
Pre-Vietnam	18	26
Vietnam	43	62
Post-Vietnam	8	12
Agent orange exposure	60	87
Service connected
100%	14	20
10 to 90%	15	22
Not service connected	40	58
Means status
Exempt from copay	23	33
Discretionary	11	16
Not applicable or missing	35	51
Veteran Integrated Service Network
VISN 1	10	15
VISN 7	12	17
VISN 17	13	19
VISN 20	12	17
7 Other VISNs	22	32

Analysis of VA administrative data as August 2015
Service connected represents percentage of care that is covered by the VA due resulting from a service-related injury
Means status indicates whether the Veteran is eligible for free or reduced cost of care

ISSN: 1472-6947